VICIn ForceRegulation
Public Health and Wellbeing Regulations 2019
Sch 3Registered medical practitioners—notifiable conditions and notification details
Start here
Get a plain-English read of Sch 3
Turn the raw legal text into a practical explanation grounded in Public Health and Wellbeing Regulations 2019.
Schedule 3—Registered medical practitioners—notifiable conditions and notification details
Regulations 91, 92 and 93
**Part 1—Notifiable conditions requiring notification as soon as practicable**
1 Anthrax
1A Avian influenza
2 Botulism
3 Cholera
4 Diphtheria
5 Food-borne and water-borne illness (2 or more related cases)
6 Haemolytic Uraemic Syndrome (HUS)
7 *Haemophilus influenzae* type b (Hib) infection (meningitis, epiglottitis, other invasive infections)
8 Hepatitis A
8A Invasive Group A Streptococcal (iGAS) disease
9 Japanese encephalitis
10 Legionellosis
11 Listeriosis
11A Lyssavirus—Australian Bat lyssavirus (ABLV)
11B Lyssavirus—other (specify)
12 Measles
13 Meningococcal infection (invasive)
14 Middle East Respiratory Syndrome coronavirus (MERS-CoV)
14A Mpox
15 Murray Valley encephalitis virus infection
16 Paratyphoid
17 Plague
18 Poliovirus infection
19 Rabies
20 Severe Acute Respiratory Syndrome (SARS)
21 Smallpox
22 Tularaemia
23 Typhoid
24 Viral haemorrhagic fevers
25 Yellow fever
**Part 2—Notifiable conditions requiring written notification within 5 business days**
1 Acute rheumatic fever (ARF)
1A Brucellosis
2 Chikungunya virus infection
3 Creutzfeldt-Jakob disease (CJD)
4 Variant Creutzfeldt-Jakob disease (vCJD)
5 Cryptosporidiosis
6 Dengue virus infection
7 *Donovanosis (*Klebsiella granulomatis* infection)
8 *Gonococcal infection
9 Hepatitis B (newly acquired)
10 Hepatitis B (unspecified)
11 Hepatitis C (newly acquired)
12 Hepatitis C (unspecified)
13 Hepatitis D
14 Hepatitis E
15 *Human Immunodeficiency Virus (HIV) infection
16 Leprosy
19 Malaria
20 Mumps
21 *Mycobacterium ulcerans*
22 Pertussis
23 Pneumococcal infection (invasive)
24 Q Fever
24A Rheumatic heart disease (RHD)
25 Rubella
26 Congenital Rubella
27 Salmonellosis
28 Shiga toxin and verotoxin producing *Escherichia coli* (STEC/VTEC)
29 Shigellosis
30 *Syphilis (less than 2 years duration)
31 *Syphilis (2 years or more duration or unspecified)
32 *Congenital syphilis
33 Tetanus
34 Tuberculosis
35 Varicella zoster infection (chickenpox)
36 Varicella zoster infection (shingles)
37 West Nile/Kunjin virus infection
Note
Part 3 of this Schedule sets out different reporting requirements for notifiable conditions marked with *.
**Part 3—Notification details**
Item 1—Case information
1.1 Family name (First 2 letters of family name only for those conditions marked with *)
1.2 Given name(s) (First 2 letters of given name only for those conditions marked with *)
1.3 Healthcare identifier (not notified for those conditions marked with *)
1.4 Medicare number (not notified for those conditions marked with *)
1.5 Date of birth
1.6 Sex
1.7 Aboriginal or Torres Strait Islander status
1.8 Residential address (postcode only for those conditions marked with *)
1.9 Contact details of patient/parent/guardian (not notified for those conditions marked with *)
Item 2—Clinical information
2.2 Mortality details
2.3 Morbidity details
2.4 Illness history and details
Item 3—Risk factor information
3.1 Risk factor details
Item 4—Reporting medical practitioner information
4.1 Family name
4.2 Given name(s)
4.3 Health service/clinic/practice name
4.4 Health service/clinic/practice address
4.5 Contact details
4.6 Medicare provider number or AHPRA registration number
4.7 Report date
Sch. 4 (Heading) amended by S.R. No. 88/2022 reg. 16(1).
Sch. 4 amended by S.R. Nos 4/2020 reg. 4, 14/2022 reg. 7, 73/2022 reg. 4. 88/2022 reg. 16(2), 27/2023 reg. 6, 52/2023 reg. 6, 10/2024 reg. 6, 12/2025 reg. 6.